Jonas Perales

Jonas Perales

Auto-generated profile, based on publicly available information

Jonas Perales

Department of Physiology and Pharmacodynamics, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2014 in Proteome Science
Verified
Journal Article
Open access
PDF file
EVEllen Vale
Ellen Vale
AHAngelo Schuabb Heringer
Angelo Schuabb Heringer
TBTatiana Barroso
Tatiana Barroso
AFAndré Teixeira da Silva Ferreira
André Teixeira da Silva Ferreira
MCMonique Nunes da Costa
Monique Nunes da Costa
VSVanildo Silveira
Vanildo Silveira
Somatic embryogenesis is a complex process regulated by numerous factors. The identification of proteins that are differentially expressed during plant development could result in the development of molecular markers of plant metabolism and provide information contributing to the monitoring and understanding of different biological responses. In addition, the identification of molecular markers could lead to the optimization of protocols allowing the use of biotechnology for papaya propagation and reproduction. This work aimed to investigate the effects of polyethylene glycol (PEG) on somatic embryo development and the protein expression profile during somatic embryo maturation in papaya (Carica papaya L.).

1 June 2005 in Toxicon
Verified
Journal Article
Closed access
JPJonas Perales
Jonas Perales
AFAna Gisele da Costa Neves Ferreira
Ana Gisele da Costa Neves Ferreira
RVRichard Hemmi Valente
Richard Hemmi Valente
GDGilberto B. Domont
Gilberto B. Domont

11 December 2002 in European Journal of Biochemistry
Verified
Journal Article
Open access
PDF file
SRSurza L. G. Rocha
Surza L. G. Rocha
Bruno LomonteBruno Lomonte
Bruno Lomonte
AFAna Gisele da Costa Neves Ferreira
Ana Gisele da Costa Neves Ferreira
MTMonique R. O. Trugilho
Monique R. O. Trugilho
IJInacio Junqueira-De-Azevedo
Inacio Junqueira-De-Azevedo
JPJonas Perales
Jonas Perales
Bothrops snake venoms are known to induce local tissue damage such as hemorrhage and myonecrosis. The opossum Didelphis marsupialis is resistant to these snake venoms and has natural venom inhibitors in its plasma. The aim of this work was to clone and study the chemical, physicochemical and biological properties of DM64, an antimyotoxic protein from opossum serum. DM64 is an acidic protein showing 15% glycosylation and with a molecular mass of 63 659 Da when analysed by MALDI‐TOF MS. It was cloned and the amino acid sequence was found to be homologous to DM43, a metalloproteinase inhibitor from D. marsupialis serum, and to human α1B‐glycoprotein, indicating the presence of five immunoglobulin‐like domains. DM64 neutralized both the in vivo myotoxicity and the in vitro cytotoxicity of myotoxins I (mt‐I/Asp49) and II (mt‐II/Lys49) from Bothrops asper venom. The inhibitor formed noncovalent complexes with both toxins, but did not inhibit the PLA2 activity of mt‐I. Accordingly, DM64 did not neutralize the anticoagulant effect of mt‐I nor its intracerebroventricular lethality, effects that depend on its enzymatic activity, and which demonstrate the dissociation between the catalytic and toxic activities of this Asp49 myotoxic PLA2. Furthermore, despite its similarity with metalloproteinase inhibitors, DM64 presented no antihemorrhagic activity against Bothrops jararaca or Bothrops asper crude venoms, and did not inhibit the fibrinogenolytic activity of jararhagin or bothrolysin. This is the first report of a myotoxin inhibitor with an immunoglobulin‐like structure isolated and characterized from animal blood.

1 December 2013 in Journal of Proteomics
Verified
Journal Article
Closed access
MLMilene Schmidt Luna
Milene Schmidt Luna
RVRichard Hemmi Valente
Richard Hemmi Valente
JPJonas Perales
Jonas Perales
MVMonica Vieira
Monica Vieira
NYNorma Yamanouye
Norma Yamanouye

26 August 2016 in Toxins
Verified
Journal Article
Open access
PDF file
VBViviane A. Bastos
Viviane A. Bastos
FGFrancisco Gomes-Neto
Francisco Gomes-Neto
JPJonas Perales
Jonas Perales
AFAna Gisele da Costa Neves Ferreira
Ana Gisele da Costa Neves Ferreira
RVRichard Hemmi Valente
Richard Hemmi Valente
The research on natural snake venom metalloendopeptidase inhibitors (SVMPIs) began in the 18th century with the pioneering work of Fontana on the resistance that vipers exhibited to their own venom. During the past 40 years, SVMPIs have been isolated mainly from the sera of resistant animals, and characterized to different extents. They are acidic oligomeric glycoproteins that remain biologically active over a wide range of pH and temperature values. Based on primary structure determination, mammalian plasmatic SVMPIs are classified as members of the immunoglobulin (Ig) supergene protein family, while the one isolated from muscle belongs to the ficolin/opsonin P35 family. On the other hand, SVMPIs from snake plasma have been placed in the cystatin superfamily. These natural antitoxins constitute the first line of defense against snake venoms, inhibiting the catalytic activities of snake venom metalloendopeptidases through the establishment of high-affinity, non-covalent interactions. This review presents a historical account of the field of natural resistance, summarizing its main discoveries and current challenges, which are mostly related to the limitations that preclude three-dimensional structural determinations of these inhibitors using “gold-standard” methods; perspectives on how to circumvent such limitations are presented. Potential applications of these SVMPIs in medicine are also highlighted.

16 July 2022 in Cell Death Discovery
Verified
Journal Article
Open access
PDF file
MTMonique R. O. Trugilho
Monique R. O. Trugilho
IAIsaclaudia G. Azevedo-Quintanilha
Isaclaudia G. Azevedo-Quintanilha
JGJoão S. M. Gesto
João S. M. Gesto
EMEmilly Caroline S. Moraes
Emilly Caroline S. Moraes
SMSamuel C. Mandacaru
Samuel C. Mandacaru
PBPatricia Bozza
Patricia Bozza
Coronavirus disease 2019 (COVID-19) has affected over 400 million people worldwide, leading to 6 million deaths. Among the complex symptomatology of COVID-19, hypercoagulation and thrombosis have been described to directly contribute to lethality, pointing out platelets as an important SARS-CoV-2 target. In this work, we explored the platelet proteome of COVID-19 patients through a label-free shotgun proteomics approach to identify platelet responses to infection, as well as validation experiments in a larger patient cohort. Exclusively detected proteins (EPs) and differentially expressed proteins (DEPs) were identified in the proteomic dataset and thus classified into biological processes to map pathways correlated with pathogenesis. Significant changes in the expression of proteins related to platelet activation, cell death, and antiviral response through interferon type-I were found in all patients. Since the outcome of COVID-19 varies highly among individuals, we also performed a cross-comparison of proteins found in survivors and nonsurvivors. Proteins belonging to the translation pathway were strongly highlighted in the nonsurvivor group. Moreover, the SARS-CoV-2 genome was fully sequenced in platelets from five patients, indicating viral internalization and preprocessing, with CD147 as a potential entry route. In summary, platelets play a significant role in COVID-19 pathogenesis via platelet activation, antiviral response, and disease severity.